doxazosin

Generic: doxazosin

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 2 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-153
Product ID 71610-153_c783db8d-05dc-4b11-9f6a-bcb821b73cac
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075580
Listing Expiration 2026-12-31
Marketing Start 2015-04-09

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610153
Hyphenated Format 71610-153

Supplemental Identifiers

RxCUI
197626 197628
UNII
86P6PQK0MU

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin (source: ndc)
Application Number ANDA075580 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 90 TABLET in 1 BOTTLE (71610-153-60)
source: ndc

Packages (1)

Ingredients (1)

doxazosin mesylate (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c783db8d-05dc-4b11-9f6a-bcb821b73cac", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197626", "197628"], "spl_set_id": ["f1dc70f6-4329-46da-8990-7bd6eec9d37d"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-153-60)", "package_ndc": "71610-153-60", "marketing_start_date": "20180918"}], "brand_name": "Doxazosin", "product_id": "71610-153_c783db8d-05dc-4b11-9f6a-bcb821b73cac", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-153", "generic_name": "Doxazosin", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "2 mg/1"}], "application_number": "ANDA075580", "marketing_category": "ANDA", "marketing_start_date": "20150409", "listing_expiration_date": "20261231"}